Emergent BioSolutions Inc.EBSNYSE

Revenue (LTM)

$743M

-28.8% YoY

Net Income (LTM)

$53M

+127.6% YoY

Free Cash Flow

$157M

Revenue CAGR (5Y)

-19.6%

Marginsdeclining

FCF$0.2B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1,774	1,118↓37.0%	1,049↓6.1%	1,044↓0.5%	743↓28.8%
Gross Profit	793	473↓40.4%	360↓23.9%	375↑4.3%	351↓6.6%
Operating Income	341	-170↓149.8%	-726↓327.3%	-109↑85.0%	110↑201.4%
Net Income	220	-212↓196.4%	-761↓259.4%	-191↑74.9%	53↑127.6%
EBITDA	504	16↓96.9%	-47↓399.4%	53↑213.6%	209↑290.4%
EPS Diluted	4.06	-4.47↓210.1%	-14.85↓232.2%	-3.60↑75.8%	0.93↑125.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	576	643↑11.5%	112↓82.6%	100↓10.9%	205↑106.4%
Total Current Assets	1,270	1,210↓4.7%	680↓43.9%	599↓11.9%	663↑10.7%
Total Assets	2,958	3,166↑7.1%	1,823↓42.4%	1,390↓23.8%	1,319↓5.1%
Total Current Liabilities	374	1,229↑228.6%	651↓47.0%	162↓75.1%	132↓18.6%
Total Liabilities	1,346	1,779↑32.1%	1,174↓34.0%	907↓22.7%	796↓12.2%
Total Equity	1,612	1,388↓13.9%	649↓53.2%	483↓25.6%	523↑8.2%
Total Debt	871	1,426↑63.8%	860↓39.7%	676↓21.4%	572↓15.4%
Net Debt	295	784↑166.0%	749↓4.5%	577↓23.0%	367↓36.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	321	-34↓110.6%	-206↓505.0%	59↑128.5%	171↑190.6%
Capital Expenditure	-225	-116↑48.5%	-52↑55.4%	-23↑55.6%	-14↑39.7%
Free Cash Flow	96	-150↓256.0%	-258↓72.0%	36↑113.9%	157↑338.0%
Stock-Based Comp	42	45↑6.4%	23↓48.8%	18↓22.1%	16↓10.0%
Net Change in Cash	-45	66↑246.7%	-531↓900.8%	-6↑98.9%	104↑1796.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance